Selective Uptake of Boronated LDL in Melanoma
Author Information
Author(s): Y Setiawan, DE Moore, BJ Allen
Primary Institution: The University of Sydney
Hypothesis
Can boronated low-density lipoprotein (LDL) be used as a targeted drug delivery system for melanoma treatment?
Conclusion
The study demonstrated that diet supplementation can enhance the selective uptake of boronated LDL in melanoma xenografts, achieving a tumor-blood boron concentration ratio of 5:1.
Supporting Evidence
- Boronated LDL showed a significant increase in tumor uptake compared to control.
- Diet supplementation with coconut oil and cholesterol improved boron delivery to tumors.
- The tumor-blood boron concentration ratio achieved was 5:1.
Takeaway
Researchers found that adding certain fats to the diet helped deliver a special type of fat called boronated LDL to tumors better than normal diets.
Methodology
Biodistribution studies were performed in BALB/c mice with subcutaneous melanoma xenografts after diet supplementation and administration of boronated LDL.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Adult male BALB/c mice, 6-8 weeks old.
Statistical Information
P-Value
0.0043
Statistical Significance
p=0.0043
Want to read the original?
Access the complete publication on the publisher's website